156 related articles for article (PubMed ID: 6317239)
1. Autoantibodies in three populations of Burkitt's lymphoma patients.
Vainio E; Lenoir GM; Franklin RM
Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
[TBL] [Abstract][Full Text] [Related]
2. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
Geser A; Brubaker G; Olwit GW
Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
[TBL] [Abstract][Full Text] [Related]
3. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated Burkitt's lymphoma in India.
Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
[TBL] [Abstract][Full Text] [Related]
5. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma.
Judson SC; Henle W; Henle G
N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
Jondal M; Gunven P
Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
de-Thé G
IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
[TBL] [Abstract][Full Text] [Related]
8. [Burkitt's lymphoma-Epstein-Barr virus association in western Algeria. Clinical, cytological and serological aspects apropos of 34 pediatric cases].
Meziane F; Aguercif M; Chevallier A; Lavoue MF; Boukli H; Mehadji M; Boughermouh M
Pediatrie; 1985 Mar; 40(2):87-98. PubMed ID: 3001633
[TBL] [Abstract][Full Text] [Related]
9. Implications of a vaccine for the prevention of Epstein-Barr virus infection: ethical and logistic considerations.
Epstein MA
Cancer Res; 1976 Feb; 36(2 pt 2):711-4. PubMed ID: 175931
[TBL] [Abstract][Full Text] [Related]
10. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)].
Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M
Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275
[TBL] [Abstract][Full Text] [Related]
11. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr capsid antigen.
Henle W; Henie G
J Natl Cancer Inst; 1977 Mar; 58(3):785-6. PubMed ID: 190417
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
14. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients.
Lamelin JP; de-The G; Revillard JP; Gabbiani G
IARC Sci Publ (1971); 1978; (20):523-36. PubMed ID: 215532
[TBL] [Abstract][Full Text] [Related]
16. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
17. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
18. [Epstein-Barr virus and Burkitt's lymphoma].
Joab I
Med Trop (Mars); 1999; 59(4 Pt 2):499-502. PubMed ID: 10901854
[TBL] [Abstract][Full Text] [Related]
19. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
Morrow RH; Sever JL; Henderson BE
Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
[No Abstract] [Full Text] [Related]
20. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
